• Donor Login
  • Contact Us
  • JDRF
JDRF T1D Fund
  • About
  • Investment Strategy
  • Portfolio
  • Our People
  • Venture Philanthropy
  • News
  • Donor Login
  • Get in touch

News and Press

Sean Doherty Speaks at TEDx Boston On Reimagining Philanthropy to Drive Cures

October 25, 2022

Inversago Pharma Raises $95 million CAD in Series C Financing

October 17, 2022 | MONTREAL

Sean Doherty Appears on IVY Podcast to Discuss the Power of Venture Philanthropy

September 16, 2022

T1D Fund in the News

Inversago Pharma receives IND clearance for Phase 2 trial of INV-202 in Diabetic Kidney Disease

September 15, 2022

T1D Fund in the News

Seraxis Announces Appointment of Chief Medical Officer, Dr. Paul Strumph

August 30, 2022

About the JDRF T1D Fund

Our aim is to create a new investment market aimed at delivering solutions to those living with or at risk of developing T1D. Launched in December 2016, the T1D Fund is a combination of venture capital and philanthropy focused solely on T1D. It’s the first scale, mission-driven venture philanthropy fund focused on equity investments in companies developing life-changing T1D products. The portfolio consists of therapeutics, devices, vaccines, and diagnostics. We already have made several investments and the list will only continue to grow.


  • About
  • Investment
    Strategy
  • Portfolio
  • Our People
  • Venture
    Philanthropy
  • News
Contact Us

For more information email us at t1dfund@jdrf.org

JDRF T1D Fund

© Copyright 2018. All Rights Reserved